PCVX Research and Charts

PCVX - Vaxcyte Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2025-02-04 (Delayed quote data 2025-01-06)

Last 85.99	Change ⇑ +1.13 (+1.33%)	Volume 879,014
	Open 84.23	High 86.74	Low 83.90

8EMA (Daily) 84.58	40EMA (Daily) 90.53	50EMA (Daily) 91.84	STO (Daily) 27.269	MACD Hist (Daily) 0.567
8EMA (Weekly) 88.632	40EMA (Weekly) 86.73	50EMA (Weekly) 83.63	STO (Weekly) 8.762	MACD Hist (Weekly) -6.079


Company Profile
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-XP, VAX-A1, and VAX-PG.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.